Table 1 : Demographic and base line characteristics of the study participants.
Variable | Group (A) (n=20) | Group (B) (n=20) | p-value |
X±SD | X±SD | ||
Age(year) | 48.25±0.63 | 47.95±0.95 | 0.48 |
Height(cm) | 160±1.6 | 164±1.2 | 0.08 |
Body weight(Kg) | 105±2.15 | 100±2.9 | 0.25 |
BMI(Kg/m2) | 39.01±0.67 | 39.14±0.87 | 0.94 |
WC(cm) | 114.3±1.68 | 116.4±1.85 | 0.41 |
LANSS | 21.75±0.45 | 21.80±0.42 | 0.93 |
LEFS | 55.30±1.18 | 56.35±1.24 | 0.54 |
OGTT: | |||
-FBG(mg/dl) | 118.1±1.11 | 116.8±1.37 | 0.31 |
-60-minute PP(mg/dl) | 182.2±8.40 | 206.2±5.55 | 0.06 |
-90-minute PP(mg/dl) | 175.4±8.2 | 188±3.75 | 0.17 |
-120-minute PP(mg/dl) | 156.6±5.47 | 166.45±2.2 | 0.1 |
X: mean; SD: standard deviation; BMI: body mass index;
WC: waist circumference;
LANSS: Leeds Assessment of Neuropathic symptoms and signs Scale;
LEFS: lower extremity functional scale; OGTT: oral glucose tolerance test;
FBG: fasting blood glucose; PP: post prandial